Status:
COMPLETED
Effectiveness and Implementation of the Assessment of Burden of Chronic Conditions (ABCC)-Tool
Lead Sponsor:
Maastricht University
Collaborating Sponsors:
Netherlands Instititute for Health Services Research
TNO
Conditions:
Chronic Obstructive Pulmonary Disease
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is designed to evaluate the effectiveness and implementation of the Assessment of Burden of Chronic Conditions (ABCC)-tool for patients with COPD, asthma, diabetes mellitus type 2 or heart ...
Eligibility Criteria
Inclusion
- diagnosis COPD, asthma, Diabetes Mellitus type 2 and/or heart failure
- can understand and read the Dutch language
Exclusion
- COPD or asthma: used prednisone due to an exacerbation less than six weeks ago
- Heart failure or diabetes mellitus type 2: hospitalized less than six weeks ago
- Healthcare providers or patients who have already used the Assessment of Burden of COPD-tool are excluded from the control group
- Patients who have already used the Assessment of Burden of COPD-tool will be excluded from the intervention group
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
237 Patients enrolled
Trial Details
Trial ID
NCT04127383
Start Date
November 1 2019
End Date
November 1 2022
Last Update
March 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University
Maastricht, Limburg, Netherlands, 6200MD